University of Miami
R

New Therapy Options for Neuromyelitis Optica Spectrum Disorder: Eculizumab, Inebilizumab and Stralizumab for AQP4 Ab Positive NMOSD

By University of Miami FEATURING Ramon Flores Gonzalez
By University of Miami FEATURING Ramon Flores Gonzalez
28 views
July 23, 2021
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
28:41
University of Miami

Management of Neuromyelitis Optica Spectrum Disorders (NMOSD) in 2022

Feat. L. Tornes
18:31
University of Miami

Optical Coherence Tomography (OCT) in Neuromyelitis Optica Spectrum …

Feat. H. Jiang
15:17
University of Miami

Anti-C5 Complement Therapy in NMO: Eculizumab and Ravulizumab

Feat. F. Nelson
30:05
2023 Conference Coverage

Neuroimaging Case Studies in Inflammation and Demyelination

Feat. U. Kaunzner
18:18
University of Miami

IL6 Receptor Inhibition in Treatment of NMOSD

Feat. K. Rammohan
15:37
University of Miami

The Role of Optical Coherence Tomography in Neurology

Feat. H. Jiang
32:34
University of Miami

Everything a Neurologist Needs to Know About NMO & MOG

Feat. M. Levy
48:54
Olga Rosenvald Thon

The Current Spectrum of NMOSD

21:07
University of Miami

MOG Antibody Disease (MOGAD) Update

Feat. M. Ortega
34:59
McMaster University Department of Medicine

Challenges of Neurological Presentations in Rheumatic Diseases: Lab …

Feat. E. Shosha
31:43
Cedars Sinai

Diagnostic Criteria and Biomarkers on the Horizon (MRI, OCT, Blood)

Feat. O. Al-Louzi
33:02
University of Miami

NMO and MOG Case Presentations

Feat. H. Jiang, M. Levy, F. Nelson, K. Rammohan, M. Ortega
20:19
Rush University Medical Center

Pregnancy and MS/NMOSD

Feat. A. Miravalle
22:34
University of Miami

COVID-19 Infection in Multiple Sclerosis and Neuromyelitis Optica Sp…

Feat. C. Dixon
17:06
ECTRIMS

Infection Risk Associated With New NMOSD Treatments: Anti-CD19 (Ineb…

Feat. B. Weinshenker
04:55
2023 Conference Coverage

Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with…

Feat. F. Paul
54:13
ZINCARE

Neuromyelitis Optica Spectrum Disorder (NMOSD), MOG-IgG Associated D…

Feat. E. Sotirchos
23:00
Cedars Sinai

Treatment Options on the Horizon for Neuroimmunological Disorders

Feat. M. Sy
22:07
Cedars Sinai

Vaccination Considerations with DIsease Modifying Agents for Treatme…

Feat. N. Sicotte
24:11
Cedars Sinai

Multiple Sclerosis and Neuromyelitis Optica Susceptibility and Other…

Feat. L. Amezcua